Philip R. Wagenheim

Co-Founder at Broadband Capital Management LLC

Philip R. Wagenheim

Philip R. Wagenheim

Co-Founder at Broadband Capital Management LLC

Overview
Career Highlights

Committed Capital Acquisition Corp. Iii
Committed Capital Acquisition Corp II
Immunome, Inc.

RelSci Relationships

358

Number of Boards

8

Birthday

1970

Age

48

Relationships
RelSci Relationships are individuals Philip R. Wagenheim likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Chairman at Brand & Services Acquisition Corp.

Relationship likelihood: Strong

Senior Managing Director at Broadband Capital Management LLC

Relationship likelihood: Strong

Founder at Immunome, Inc.

Relationship likelihood: Strong

Co-Founder & Managing Partner at Syncarpha Capital

Relationship likelihood: Strong

President & Chief Executive Officer at Immunome, Inc.

Relationship likelihood: Strong

President, Secretary & Director at Committed Capital Acquisition Corp II

Relationship likelihood: Strong

Co-Founder at Militia Hill Ventures

Relationship likelihood: Strong

Executive Chairman at The ONE Group Hospitality, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Treasurer at Immunome, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Surpass, Inc.

Relationship likelihood: Strong

Paths to Philip R. Wagenheim
Potential Connections via
Relationship Science
You
Philip R. Wagenheim
Co-Founder at Broadband Capital Management LLC
Education
Business Administration
Class of 1992

A private research university with more than 15,000 students from around the world, the University of Miami is a vibrant and diverse academic community focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. Led by President Donna E. Shalala, the University comprises 12 schools and colleges serving undergraduate and graduate students in more than 180 majors and programs. In 2012, U.S.News & World Report ranked UM No. 44 in its “Best Colleges” listings, the fourth year in a row it has been among the top 50, and it continued to be the highest ranked school in Florida. U.S. News also cited several of its programs in “America’s Best Graduate Schools.” Established in 1925 during the region’s famous real estate boom, UM is a major research university engaged in $360 million in research and sponsored program expenditures a year. While the majority of this work is housed at the Miller School of Medicine, investigators conduct dozens of studies in other areas, including marine science, engineering, education, and psychology

Career History
President, Secretary & Director
2011 - Current

Committed Capital Acquisition Corp. III operates as a development stage company. It intends to acquire or merge with operating businesses. The firm was organized for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, exchangeable stock transaction or other similar business transaction, one or more operating businesses or assets. The company was founded by Michael Rapoport and Philip R. Wagenheim on May 18, 2011 and is headquartered in New York, NY.

Secretary & Director
2011 - Current

Plastron Acquisition Corp. III operates as a development stage company. It was formed as a vehicle to pursue a business combination through the acquisition of or merger with an operating business. The company was founded on May 24, 2011 and is headquartered in New York, NY.

Secretary & Director
2011 - Current

Plastron Acquisition Corp. IV operates as a development stage company. It was formed as a vehicle to pursue a business combination through the acquisition of or merger with an operating business. The company was founded on June 22, 2011 and is headquartered in New York, NY.

Boards & Committees
Secretary & Director
2011 - Current

Plastron Acquisition Corp. III operates as a development stage company. It was formed as a vehicle to pursue a business combination through the acquisition of or merger with an operating business. The company was founded on May 24, 2011 and is headquartered in New York, NY.

Secretary & Director
2011 - Current

Plastron Acquisition Corp. IV operates as a development stage company. It was formed as a vehicle to pursue a business combination through the acquisition of or merger with an operating business. The company was founded on June 22, 2011 and is headquartered in New York, NY.

President, Secretary & Director
2011 - Current

Committed Capital Acquisition Corp. III operates as a development stage company. It intends to acquire or merge with operating businesses. The firm was organized for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, exchangeable stock transaction or other similar business transaction, one or more operating businesses or assets. The company was founded by Michael Rapoport and Philip R. Wagenheim on May 18, 2011 and is headquartered in New York, NY.

Transactions
Details Hidden

Immunome, Inc. raised money in a private placement transaction

Details Hidden

Walker Innovation, Inc. purchases Inventor Holdings LLC

Investments
Details Hidden

Zynerba Pharmaceuticals, Inc. engages in the research and development of drugs. Its clinical programs include synthetic cannabinoid therapeutics and patch and gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.

Public Holdings
Restricted data only for RelSci Professional users.